Conceptualizing the role of estrogens and serotonin in the development and maintenance of bulimia nervosa

Clinical Psychology Review

Volumn 30, Issue 6, 2010, Pages 655-668

  Hildebrandt, Tom ^a   Alfano, Lauren ^a   Tricamo, Michelle ^a   Pfaff, Donald W ^b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b ROCKEFELLER UNIVERSITY   (United States)

Author keywords

Brain arousal; Bulimia nervosa; Epigenetics; Estrogen; Serotonin; Sex hormones

Indexed keywords

ESTROGEN; SEROTONIN; SEROTONIN 1A RECEPTOR; SEROTONIN 2A RECEPTOR;

BEHAVIOR; BINGE EATING DISORDER; BODY WEIGHT; BULIMIA; CLINICAL FEATURE; EATING DISORDER; EPIGENETICS; FEAR; FEEDING; GENETICS; HUMAN; MOLECULAR GENETICS; NEUROSCIENCE; PATHOGENESIS; PATHOLOGY; REVIEW; RISK FACTOR; SEROTONINERGIC SYSTEM; SEX; AROUSAL; BULIMIA NERVOSA; PATHOPHYSIOLOGY; PHYSIOLOGY;

AROUSAL; BULIMIA NERVOSA; ESTROGENS; HUMANS; RISK FACTORS; SEROTONIN;

EID: 77955055054     PISSN: 02727358     EISSN: 18737811     Source Type: Journal    
DOI: 10.1016/j.cpr.2010.04.011     Document Type: Review

References (237)

1. Akimova E., Lanzenberger R., Kasper S. The serotonin-1A receptor in anxiety disorders. Biological Psychiatry 2009, 66(7):627-635.
2. Allen K.L., Byrne S.M., Forbes D., Oddy W.H. Risk factors for full- and partial-syndrome early adolescent eating disorders: A population-based pregnancy cohort study. Journal of the American Academy of Child and Adolescent Psychiatry 2009, 48(8):800-809.
3. Alyea R.A., Watson C.S. Differential regulation of dopamine transporter function and location by low concentrations of environmental estrogens and 17 beta-estradiol. Environmental Health Perspectives 2009, 117(5):778-783.
4. Alyea R.A., Watson C.S. Nongenomic mechanisms of physiological estrogen-mediated dopamine efflux. BMC Neuroscience 2009, 10:9.
5. Amargos-Bosch M., Bortolozzi A., Puig M.V., Serrats J., Adell A., Celada P., et al. Co-expression and in vivo interaction of serotonin(1A) and serotonin(2A) receptors in pyramidal neurons of prefrontal cortex. Cerebral Cortex 2004, 14(3):281-299.
6. American Psychiatric Association Diagnostic and statistical manual of mental disorders 1994, Author, Washington, DC. 4th ed.
7. Anguelova M., Benkelfat C., Turecki G. A systematic review of association studies investigating genes coding for serotonin receptors and the serotonin transporter: I. Affective disorders. Molecular Psychiatry 2003, 8(6):574-591.
8. Asarian L., Geary N. Cyclic estradiol treatment normalizes body weight and restores physiological patterns of spontaneous feeding and sexual receptivity in ovariectomized rats. Hormones and Behavior 2002, 42(4):461-471.
9. Ashby C.R., Edwards E., Wang R.Y. Electrophysiological evidence for a functional interaction between 5-HT1A and 5-HT2A receptors in the rat medial prefrontal cortex: An iontophoretic study. Synapse 1994, 17(3):173-181.
10. Attali G., Weizman A., GilAd I., Rehavi M. Opposite modulatory effects of ovarian hormones on rat brain dopamine and serotonin transporters. Brain Research 1997, 756(1-2):153-159.
11. Austin S.B., Ziyadeh N.J., Vohra S., Forman S., Gordon C.M., Prokop L.A., et al. Irregular menses linked to vomiting in a nonclinical sample: Findings from the National Eating Disorders Screening Program in high schools. The Journal of Adolescent Health 2008, 42(5):450-457.
12. Azmitia E.C. Serotonin and brain: Evolution, neuroplasticity, and homeostasis. Pharmacology of Neurogenesis and Neuroenhancement 2007, 77:31-49.
13. Baca-Garcia E., Salgado B.R., Segal H.D., Lorenzo C.V., Acosta M.N., Romero M.A., et al. A pilot genetic study of the continuum between compulsivity and impulsivity in females: The serotonin transporter promoter polymorphism. Progress in Neuropsychopharmacology & Biological Psychiatry 2005, 29(5):713-717.
14. Bacanu S.A., Bulik C.M., Klump K., Fichter M.M., Halmi K.A., Keel P., et al. Linkage analysis of anorexia and bulimia nervosa cohorts using selected behavioral phenotypes as quantitative traits or covariates. American Journal of Medical Genetics. Part B: Neuropsychiatric Genetics 2005, 139B(1):61-68. [Article].
15. Bagchi M.K., Tsai M.J., Omalley B.W., Tsai S.Y. Analysis of the mechanisms of steroid-hormone receptor-dependent gene activation in cell free systems. Endocrine Reviews 1992, 13(3):525-535.
16. Bailer U.F., Price J.C., Meltzer C.C., Mathis C.A., Frank G.K., Weissfeld L., et al. Altered 5-HT(2A) receptor binding after recovery from bulimia-type anorexia nervosa: Relationships to harm avoidance and drive for thinness. Neuropsychopharmacology 2004, 29(6):1143-1155.
17. Baniahmad A., Tsai M.J. Mechanisms of transcriptional activation by steroid-hormone receptors. Journal of Cellular Biochemistry 1993, 51(2):151-156.
18. Barnes N.M., Sharp T. A review of central 5-HT receptors and their function. Neuropharmacology 1999, 38(8):1083-1152.
19. Bendotti C., Samanin R. The role of putative 5-HT1a and 5-HT1B receptors in the control of feeding in rats. Life Sciences 1987, 41(5):635-642.
20. Benmansour S., Piotrowski J.P., Altamirano A.V., Frazer A. Impact of ovarian hormones on the modulation of the serotonin transporter by fluvoxamine. Neuropsychopharmacology 2009, 34(3):555-564.
21. Bethea C.L. Regulation of progestin receptors in raphe neurons of steroid-treated monkeys. Neuroendocrinology 1994, 60(1):50-61.
22. Bethea C.L., Brown N.A., Kohama S.G. Steroid regulation of estrogen and progestin receptor messenger ribonucleic acid in monkey hypothalamus and pituitary. Endocrinology 1996, 137(10):4372-4383.
23. Bethea C.L., Lu N.Z., Gundlah C., Streicher J.M. Diverse actions of ovarian steroids in the serotonin neural system. Frontiers in Neuroendocrinology 2002, 23(1):41-100.
24. Bethea C.L., Mirkes S.J., Shively C.A., Adams M.R. Steroid regulation of tryptophan hydroxylase protein in the dorsal raphe of macaques. Biological Psychiatry 2000, 47(6):562-576.
25. Bethea C.L., Mirkes S.J., Su A., Michelson D. Effects of oral estrogen, raloxifene and arzoxifene on gene expression in serotonin neurons of macaques. Psychoneuroendocrinology 2002, 27(4):431-445.
26. Bethea C.L., Pecins-Thompson M., Schutzer W.E., Gundlah C., Lu N.Z. Ovarian steroids and neuronal function. Molecular Neurobiology 1999, 18(2):87-123.
27. Bethea C.L., Reddy A.P., Tokuyama Y., Henderson J.A., Lima F.B. Protective actions of ovarian hormones in the serotonin system of macaques. Frontiers in Neuroendocrinology 2009, 30(2):212-238.
28. Blaustein J.D., Wade G.N. Ovarian influences on meal patterns of female rats. Physiology & Behavior 1976, 17(2):201-208.
29. Bloch M.H., Landeros-Weisenberger A., Sen S., Dombrowski P., Kelmendi B., Coric V., et al. Association of the serotonin transporter polymorphism and obsessive-compulsive disorder: Systematic review. American Journal of Medical Genetics. Part B: Neuropsychiatric Genetics 2008, 147B(6):850-858.
30. Blundell J.E. Serotonin manipulations and the structure of feeding-behavior. Appetite 1986, 7:39-56.
31. Brewerton T.D. Toward a unified theory of serotonin dysregulation in eating and related disorders. Psychoneuroendocrinology 1995, 20(6):561-590. (Review).
32. Bruce K.R., Steiger H., Joober R., Ng Ying Kin N.M., Israel M., Young S.N. Association of the promoter polymorphism -1438G/A of the 5-HT2A receptor gene with behavioral impulsiveness and serotonin function in women with bulimia nervosa. American Journal of Medical Genetics. Part B: Neuropsychiatric Genetics 2005, 137B(1):40-44.
33. Buffenstein R., Poppitt S.D., McDevitt R.M., Prentice A.M. Food-intake and menstrual-cycle - A retrospective analysis, with implication for appetite research. Physiology & Behavior 1995, 58(6):1067-1077.
34. Bulik C.M., Sullivan P.F., Kendler K.S. Heritability of binge-eating and broadly defined bulimia nervosa. Biological Psychiatry 1998, 44(12):1210-1218.
35. Bulik C.M., Sullivan P.F., Wade T.D., Kendler K.S. Twin studies of eating disorders: A review. The International Journal of Eating Disorders 2000, 27(1):1-20.
36. Burnet P.W.J., Eastwood S.L., Lacey K., Harrison P.J. The distribution of 5-HT1A and 5-HT2A receptor messenger-RNA in human brain. Brain Research 1995, 676(1):157-168.
37. Butera P.C. Estradiol and the control of food intake. Physiology and Behavior 2010, 99(2):175-180.
38. Butera P.C., Bradway D.M., Cataldo N.J. Modulation of the satiety effect of cholecystokinin by estradiol. Physiology & Behavior 1993, 53(6):1235-1238.
39. Carli M., Baviera M., Invernizzi R.W., Balducci C. Dissociable contribution of 5-HT1A and 5-HT2A receptors in the medial prefrontal cortex to different aspects of executive control such as impulsivity and compulsive perseveration in rats. Neuropsychopharmacology 2006, 31(4):757-767.
40. Carli M., Samanin R. The 5-HT(1A) receptor agonist 8-OH-DPAT reduces rats' accuracy of attentional performance and enhances impulsive responding in a five-choice serial reaction time task: Role of presynaptic 5-HT(1A) receptors. Psychopharmacology (Berl.) 2000, 149(3):259-268.
41. Chen J.Q., Brown T.R., Russo J. Regulation of energy metabolism pathways by estrogens and estrogenic chemicals and potential implications in obesity associated with increased exposure to endocrine disruptors. Biochimica et Biophysica Acta 2009, 1793(7):1128-1143.
42. Chen J.J., Li Z., Pan H., Murphy D.L., Tamir H., Koepsell H., et al. Maintenance of serotonin in the intestinal mucosa and ganglia of mice that lack the high-affinity serotonin transporter: Abnormal intestinal motility and the expression of cation transporters. The Journal of Neuroscience 2001, 21(16):6348-6361.
43. Clarke B.L., Khosla S. New selective estrogen and androgen receptor modulators. Current Opinion in Rheumatology 2009, 21(4):374-379.
44. Clegg D., Benoit S., Barrera J., Woods S. Estrogen mediates body fat distribution and brain sensitivity to adiposity signals. Diabetes 2003, 52(supplement 1):A24.
45. Clegg D., Tamashiro K., Strader A., Woods S. Gonadal hormones determine body fat distribution. Obesity Research 2004, 12(Supplement S):A126.
46. Coccaro E.F., Berman M.E., Kavoussi R.J., Hauger R.L. Relationship of prolactin response to d-fenfluramine to behavioral and questionnaire assessments of aggression in personality-disordered men. Biological Psychiatry 1996, 40(3):157-164.
47. Crandall D.L., Busler D.E., Novak T.J., Weber R.V., Kral J.G. Identification of estrogen receptor beta RNA in human breast and abdominal subcutaneous adipose tissue. Biochemical and Biophysical Research Communications 1998, 248(3):523-526.
48. Crosby R.D., Wonderlich S.A., Engel S.G., Simonich H., Smyth J., Mitchell J.E. Daily mood patterns and bulimic behaviors in the natural environment. Behaviour Research and Therapy 2009, 47(3):181-188.
49. Crow S.J., Thuras P., Keel P.K., Mitchell J.E. Long-term menstrual and reproductive function in patients with bulimia nervosa. The American Journal of Psychiatry 2002, 159(6):1048-1050.
50. Cyders M.A., Smith G.T. Emotion-based dispositions to rash action: Positive and negative urgency. Psychological Bulletin 2008, 134(6):807-828. [Review].
51. Czaja J.A., Butera P.C., McCaffrey T.A. Independent effects of estradiol on water and food intake. Behavioral Neuroscience 1983, 97(2):210-220.
52. Di Bella D., Catalano M., Cavallini M.C., Riboldi C., Bellodi L. Serotonin transporter linked polymorphic region in anorexia nervosa and bulimia nervosa. Molecular Psychiatry 2000, 5(3):233-234.
53. Diaz N.F., Diaz-Martinez N.E., Camacho-Arroyo I., Velasco I. Estradiol promotes proliferation of dopaminergic precursors resulting in a higher proportion of dopamine neurons derived from mouse embryonic stem cells. International Journal of Developmental Neuroscience 2009, 27(5):493-500.
54. Drevets W.C., Thase M.E., Moses-Kolko E.L., Price J., Frank E., Kupfer D.J., et al. Serotonin-1A receptor imaging in recurrent depression: Replication and literature review. Nuclear Medicine and Biology 2007, 34(7):865-877.
55. Eckel L.A. Estradiol: A rhythmic, inhibitory, indirect control of meal size. Physiology & Behavior 2004, 82(1):35-41.
56. Eckel L.A., Geary N. Endogenous cholecystokinin's satiating action increases during estrus in female rats. Peptides 1999, 20(4):451-456.
57. Edler C., Lipson S.F., Keel P.K. Ovarian hormones and binge eating in bulimia nervosa. Psychological Medicine 2007, 37(1):131-141.
58. Ekman A., Sundblad-Elverfors C., Landen M., Eriksson T., Eriksson E. Low density and high affinity of platelet [H-3]paroxetine binding in women with bulimia nervosa. Psychiatry Research 2006, 142(2-3):219-223.
59. Engel S.G., Corneliussen S.J., Wonderlich S.A., Crosby R.D., le Grange D., Crow S., et al. Impulsivity and compulsivity in bulimia nervosa. The International Journal of Eating Disorders 2005, 38(3):244-251.
60. Enmark E., Pelto-Huikko M., Grandien K., Lagercrantz S., Lagercrantz J., Fried G., et al. Human estrogen receptor beta-gene structure, chromosomal localization, and expression pattern. The Journal of Clinical Endocrinology and Metabolism 1997, 82(12):4258-4265.
61. Enoch M.A., Kaye W.H., Rotondo A., Greenberg B.D., Murphy D.L., Goldman D. 5-HT2A promoter polymorphism -1438G/A, anorexia nervosa, and obsessive-compulsive disorder. Lancet 1998, 351(9118):1785-1786.
62. Estrada-Camarena E., Fernandez-Guasti A., Lopez-Rubalcava C. Participation of the 5-HT1A receptor in the antidepressant-like effect of estrogens in the forced swimming test. Neuropsychopharmacology 2006, 31(2):247-255.
63. Estrada-Camarena E., Lopez-Rubalcava C., Fernandez-Guasti A. Facilitating antidepressant-like actions of estrogens are mediated by 5-HT1A and estrogen receptors in the rat forced swimming test. Psychoneuroendocrinology 2006, 31(8):905-914.
64. Faris P.L., Eckert E.D., Kim S.W., Meller W.H., Pardo J.V., Goodale R.L., et al. Evidence for a vagal pathophysiology for bulimia nervosa and the accompanying depressive symptoms. Journal of Affective Disorders 2006, 92(1):79-90.
65. Faris P.L., Hofbauer R.D., Daughters R., Vandenlangenberg E., Iversen L., Goodale R.L., et al. De-stabilization of the positive vago-vagal reflex in bulimia nervosa. Physiology & Behavior 2008, 94(1):136-153.
66. Fichter M.M., Leibl K., Rief W., Brunner E., Schmidt-Auberger S., Engel R.R. Fluoxetine versus placebo: A double-blind study with bulimic inpatients undergoing intensive psychotherapy. Pharmacopsychiatry 1991, 24(1):1-7.
67. Fischer S., Smith G.T., Cyders M.A. Another look at impulsivity: A meta-analytic review comparing specific dispositions to rash action in their relationship to bulimic symptoms. Clinical Psychology Review 2008, 28(8):1413-1425.
68. Fisher P.M., Meltzer C.C., Price J.C., Coleman R.L., Ziolko S.K., Becker C., et al. Medial prefrontal cortex 5-HT2A density is correlated with amygdala reactivity, response habituation, and functional coupling. Cerebral Cortex 2009, 19(11):2499-2507.
69. Frank G.K., Bailer U.F., Henry S., Wagner A., Kaye W.H. Neuroimaging studies in eating disorders. CNS Spectrums 2004, 9(7):539-548.
70. Frieling H., Bleich S., Otten J., Romer K.D., Kornhuber J., de Zwaan M., et al. Epigenetic downregulation of atrial natriuretic peptide but not vasopressin mRNA expression in females with eating disorders is related to impulsivity. Neuropsychopharmacology 2008, 33(11):2605-2609.
71. Frieling H., Romer K.D., Scholz S., Mittelbach F., Wilhelm J., De Zwaan M., et al. Epigenetic dysregulation of dopaminergic genes in eating disorders. International Journal of Eating Disorders 2009, 34(4):550-560.
72. Frokjaer V.G., Mortensen E.L., Nielsen F.A., Haugbol S., Pinborg L.H., Adams K.H., et al. Frontolimbic serotonin 2A receptor binding in healthy subjects is associated with personality risk factors for affective disorder. Biological Psychiatry 2008, 63(6):569-576.
73. Garey J., Goodwillie A., Frohlich J., Morgan M., Gustafsson J.A., Smithies O., et al. Genetic contributions to generalized arousal of brain and behavior. Proceedings of the National Academy of Science 2003, 100(19):11019-11022.
74. Geary N. Estradiol, CCK and satiation. Peptides 2001, 22(8):1251-1263.
75. Gendall K.A., Bulik C.M., Joyce P.R., McIntosh V.V., Carter F.A. Menstrual cycle irregularity in bulimia nervosa. Associated factors and changes with treatment. Journal of Psychosomatic Research 2000, 49(6):409-415.
76. Gioiosa L., Fissore E., Ghirardelli G., Parmigiani S., Palanza P. Developmental exposure to low-dose estrogenic endocrine disruptors alters sex differences in exploration and emotional responses in mice. Hormones & Behavior 2007, 52(3):307-316.
77. Gladis M.M., Walsh B.T. Premenstrual exacerbation of binge eating in bulimia. American Journal of Psychiatry 1987, 144(12):1592-1595.
78. Gobbi G., Murphy D.L., Lesch K., Blier P. Modifications of the serotonergic system in mice lacking serotonin transporters: An in vivo electrophysiological study. The Journal of Pharmacology and Experimental Therapeutics 2001, 296(3):987-995.
79. Goldstein D.J., Wilson M.G., Ascroft R.C., al-Banna M. Effectiveness of fluoxetine therapy in bulimia nervosa regardless of comorbid depression. International Journal of Eating Disorders 1999, 25(1):19-27.
80. Goldstein D.J., Wilson M.G., Thompson V.L., Potvin J.H., Rampey A.H. Long-term fluoxetine treatment of bulimia nervosa. Fluoxetine Bulimia Nervosa Research Group. British Journal of Psychiatry 1995, 166(5):660-666.
81. Gorwood P. Eating disorders, serotonin transporter polymorphisms and potential treatment response. American Journal of Pharmacogenetics 2004, 4:9-17.
82. Gottesmann C. Brain inhibitory mechanisms involved in basic and higher integrated sleep processes. Brain Research Reviews 2004, 45(3):230-249.
83. Greenberg B.D., Li Q., Lucas F.R., Hu S., Sirota L.A., Benjamin J., et al. Association between the serotonin transporter promoter polymorphism and personality traits in a primarily female population sample. American Journal of Medical Genetics 2000, 96(2):202-216.
84. Grun F., Blumberg B. Endocrine disrupters as obesogens. Molecular and Cellular Endocrinology 2009, 304(1-2):19-29.
85. Grun F., Blumberg B. Minireview: The case for obesogens. Molecular Endocrinology 2009, 23(8):1127-1134.
86. Gruninger T.R., LeBoeuf B., Liu Y.S., Garcia L.R. Molecular signaling involved in regulating feeding and other motivated behaviors. Molecular Neurobiology 2007, 35(1):1-19.
87. Guido G.K.W., Meltzer C.C., Price J., Drevets W.C., Greer P., Mathis C., et al. Alterations of 5HT1A and 2A receptors persist after recovery from anorexia and bulimia nervosa. Biological Psychiatry 2002, 51(8):33.
88. Gundlah C., Kohama S.G., Mirkes S.J., Garyfallou V.T., Urbanski H.F., Bethea C.L. Distribution of estrogen receptor beta (ERP) mRNA in hypothalamus, midbrain and temporal lobe of spayed macaque: Continued expression with hormone replacement. Molecular Brain Research 2000, 76(2):191-204.
89. Gundlah C., Lu N.Z., Bethea C.L. Ovarian steroid regulation of monoamine oxidase-A and B mRNAs in the macaque dorsal raphe and hypothalamic nuclei. Psychopharmacology 2002, 160(3):271-282.
90. Gundlah C., Pecins-Thompson M., Schutzer W.E., Bethea C.L. Ovarian steroid effects on serotonin 1A, 2A and 2C receptor mRNA in macaque hypothalamus. Molecular Brain Research 1999, 63(2):325-339.
91. Haddjeri N., Lavoie N., Blier P. Electrophysiological evidence for the tonic activation of 5-HT(1A) autoreceptors in the rat dorsal raphe nucleus. Neuropsychopharmacology 2004, 29(10):1800-1806.
92. Hannon J., Hoyer D. Molecular biology of 5-HT receptors. Behavioural Brain Research 2008, 195(1):198-213.
93. Hansenne M., Ansseau M. Harm avoidance and serotonin. Biological Psychology 1999, 51(1):77-81.
94. Hayward C., Killen J.D., Wilson D.M., Hammer L.D., Litt I.F., Kraemer H.C., et al. Psychiatric risk associated with early puberty in adolescent girls. Journal of the American Academy of Child and Adolescent Psychiatry 1997, 36(2):255-262.
95. Heck A., Lieb R., Ellgas A., Pfister H., Lucae S., Roeske D., et al. Investigation of 17 candidate genes for personality traits confirms effects of the HTR2A gene on novelty seeking. Genes, Brain, and Behavior 2009, 8(4):464-472.
96. Hettema J.M., Neale M.C., Kendler K.S. Physical similarity and the equal environment assumption in twin studies of psychiatric disorders. Behavioral Genetics 1995, 25(4):327-335.
97. Hiroi R., McDevitt R.A., Neumaier J.F. Estrogen selectively increases tryptophan hydroxylase-2 mRNA expression in distinct subregions of rat midbrain raphe nucleus: Association between gene expression and anxiety behavior in the open field. Biological Psychiatry 2006, 60(3):288-295.
98. Hiroi R., Neumaier J.F. Estrogen decreases 5-HT1B autoreceptor mRNA in selective subregion of rat dorsal raphe nucleus: Inverse association between gene expression and anxiety behavior in the open field. Neuroscience 2009, 158(2):456-464.
99. Hoek H.W. Incidence, prevalence and mortality of anorexia nervosa and other eating disorders. Current Opinion in Psychiatry 2006, 19(4):389-394.
100. Hoek H.W., van Hoeken D. Review of the prevalence and incidence of eating disorders. The International Journal of Eating Disorders 2003, 34(4):383-396.
101. Hoffman B.J., Hansson S.R., Mezey E., Palkovits M. Localization and dynamic regulation of biogenic amine transporters in the mammalian central nervous system. Frontiers in Neuroendocrinology 1998, 19(3):187-231.
102. Holmes A., Murphy D.L., Crawley J.N. Abnormal behavioral phenotypes of serotonin transporter knockout mice: Parallels with human anxiety and depression. Biological Psychiatry 2003, 54(10):953-959.
103. Hornung J.P. The human raphe nuclei and the serotonergic system. Journal of Chemical Neuroanatomy 2003, 26(4):331-343.
104. Hudson J.I., Hiripi E., Pope H.G., Kessler R.C. The prevalence and correlates of eating disorders in the national comorbidity survey replication. Biological Psychiatry 2007, 61(3):348-358.
105. Jacobi C., Hayward C., de Zwann M., Kraemer H.C., Agras W.S. Coming to terms with risk factors for eating disorders: Application of risk terminology and suggestions for a general taxonomy. Psychological Bulletin 2004, 130(1):19-65.
106. Jacobs B.L., Azmitia E.C. Structure and function of the brain-serotonin system. Physiological Reviews 1992, 72(1):165-229.
107. Justo R., Frontera M., Pujol E., Rodriguez-Cuenca S., Llado I., Garcia-Palmer F.J., et al. Gender-related differences in morphology and thermogenic capacity of brown adipose tissue mitochondrial subpopulations. Life Sciences 2005, 76(10):1147-1158.
108. Kasamo K., Suzuki T., Tada K., Ueda N., Matsuda E., Ishikawa K., et al. Endogenous 5-HT tonically inhibits spontaneous firing activity of dorsal hippocampus CA1 pyramidal neurons through stimulation of 5-HT(1A) receptors in quiet awake rats: In vivo electrophysiological evidence. Neuropsychopharmacology 2001, 24(2):141-151.
109. Katzenellenbogen J.A., Muthyala R., Katzenellenbogen B.S. Nature of the ligand-binding pocket of estrogen receptor alpha and beta: The search for subtype-selective ligands and implications for the prediction of estrogenic activity. Pure and Applied Chemistry 2003, 75(11-12):2397-2403.
110. Kaye W.H. Neurobiology of anorexia and bulimia nervosa. Physiology & Behavior 2008, 121-135.
111. Kaye W.H., Frank G.K., Meltzer C.C., Price J.C., McConaha C.W., Crossan P.J., et al. Altered serotonin 2A receptor activity in women who have recovered from bulimia nervosa. The American Journal of Psychiatry 2001, 158(7):1152-1155.
112. Kelly M.J., Moss R.L., Dudley C.A. Differential sensitivity of preoptic-septal neurons to microelectrophoresed estrogen during the estrous cycle. Brain Research 1976, 114(1):152-157.
113. Kelly M.J., Moss R.L., Dudley C.A., Fawcett C.P. The specificity of the response of preoptic-septal area neurons to estrogen: 17Alpha-estradiol versus 17beta-estradiol and the response of extrahypothalamic neurons. Experimental Brain Research 1977, 30(1):43-52.
114. Kelly M.J., Ronnekleiv O.K. Membrane-initiated estrogen signaling in hypothalamic neurons. Molecular and Cellular Endocrinology 2008, 290(1-2):14-23.
115. Kelly M.J., Ronnekleiv O.K. Control of CNS neuronal excitability by estrogens via membrane-initiated signaling. Molecular and Cellular Endocrinology 2009, 308(1-2):17-25.
116. Klump K.L., Bulik C.M., Kaye W.H., Treasure J., Tyson E. Academy of Eating Disorders position paper: Eating disorders are serious mental illnesses. The International Journal of Eating Disorders 2009, 42(2):97-103.
117. Klump K.L., Gobrogge K.L., Perkins P.S., Thorne D., Sisk C.L., Marc Breedlove S. Preliminary evidence that gonadal hormones organize and activate disordered eating. Psychological Medicine 2006, 36(4):539-546.
118. Klump K.L., Keel P.K., Culbert K.M., Edler C. Ovarian hormones and binge eating: Exploring associations in community samples. Psychological Medicine 2008, 38(12):1749-1757.
119. Klump K.L., McGue M., Iacono W.G. Genetic relationships between personality and eating attitudes and behaviors. Journal of Abnormal Psychology 2002, 111(2):380-389.
120. Klump K.L., Perkins P.S., Alexandra Burt S., McGue M., Iacono W.G. Puberty moderates genetic influences on disordered eating. Psychological Medicine 2007, 37(5):627-634.
121. Kostanyan A., Nazaryan K. Rat brain glycolysis regulation by estradiol-17 beta. Biochimica et Biophysica Acta 1992, 1133(3):301-306.
122. Krajnak K., Rosewell K.L., Duncan M.J., Wise P.M. Aging, estradiol and time of day differentially affect serotonin transporter binding in the central nervous system of female rats. Brain Research 2003, 990(1-2):87-94.
123. Kuikka J.T., Tammela L., Karhunen L., Rissanen A., Bergstrom K.A., Naukkarinen H., et al. Reduced serotonin transporter binding in binge eating women. Psychopharmacology 2001, 155(3):310-314.
124. Kuiper G., Carlsson B., Grandien K., Enmark E., Haggblad J., Nilsson S., et al. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 1997, 138(3):863-870. [Article].
125. Kumagai S., Holmang A., Bjorntorp P. The effects of oestrogen and progesterone on insulin sensitivity in female rats. Acta Physiologica Scandinavia 1993, 149(1):91-97.
126. Lascelles K.R.R., Field A.P., Davey G.C.L. Using foods as CSs and body shapes as UCSs: A putative role for associative learning in the development of eating disorders. Behavior Therapy 2003, 34(2):213-235.
127. Le Saux M., Di Paolo T. Changes in 5-HT1A receptor binding and G-protein activation in the rat brain after estrogen treatment: Comparison with tamoxifen and raloxifene. Journal of Psychiatry & Neuroscience 2005, 30(2):110-117.
128. Leon G.R., Keel P.K., Klump K.L., Fulkerson J.A. The future of risk factor research in understanding the etiology of eating disorders. Psychopharmacology Bulletin 1997, 33(3):405-411.
129. Lesch K.P., Bengel D., Heils A., Sabol S.Z., Greenberg B.D., Petri S., et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 1996, 274(5292):1527-1531.
130. Lester N.A., Keel P.K., Lipson S.F. Symptom fluctuation in bulimia nervosa: Relation to menstrual-cycle phase and cortisol levels. Psychological Medicine 2003, 33(1):51-60.
131. Lilenfeld L.R.R., Wonderlich S., Riso L.P., Crosby R., Mitchell J. Eating disorders and personality: A methodological and empirical review. Clinical Psychology Review 2006, 26(3):299-320.
132. Liu D., Diorio J., Tannenbaum B., Caldji C., Francis D., Freedman A., et al. Maternal care, hippocampal glucocorticoid receptors, and hypothalamic-pituitary-adrenal responses to stress. Science 1997, 277(5332):1659-1662.
133. Loucks A.B. Energy availability, not body fatness, regulates reproductive function in women. Exercise and Sport Sciences Reviews 2003, 31(3):144-148.
134. Lu N.Z., Eshleman A.J., Janowsky A., Bethea C.L. Ovarian steroid regulation of serotonin reuptake transporter (SERT) binding, distribution, and function in female macaques. Molecular Psychiatry 2003, 8(3):353-360.
135. Lund T.D., Rovis T., Chung W.C.J., Handa R.J. Novel actions of estrogen receptor-beta on anxiety-related behaviors. Endocrinology 2005, 146(2):797-807.
136. Lutter M., Nestler E.J. Homeostatic and hedonic signals interact in the regulation of food intake. The Journal of Nutrition 2009, 139(3):629-632.
137. Madrid J.A., Lopez-Bote C., Martin E. Effect of neonatal androgenization on the circadian rhythm of feeding behavior in rats. Physiology & Behavior 1993, 53(2):329-335.
138. Mancilla-Diaz J.M., Escartin-Perez R.E., Lopez-Alonso V.E., Cruz-Morales S.E. Effect of 5-HT in mianserin-pretreated rats on the structure of feeding behavior. European Neuropsychopharmacology 2002, 12(5):445-451.
139. Mannoury la Cour C., Boni C., Hanoun N., Lesch K.P., Hamon M., Lanfumey L. Functional consequences of 5-HT transporter gene disruption on 5-HT(1a) receptor-mediated regulation of dorsal raphe and hippocampal cell activity. The Journal of Neuroscience 2001, 21(6):2178-2185.
140. Manta S., Dong J., Debonnel G., Blier P. Enhancement of the function of rat serotonin and norepinephrine neurons by sustained vagus nerve stimulation. Journal of Psychiatry & Neuroscience 2009, 34(4):9. [Article].
141. McEwen B.S. Estrogen actions throughout the brain. Recent Progress in Hormone Research 2002, 57:357-384.
142. McQueen J.K., Wilson H., Dow R.C., Fink G. Oestradiol-17 beta increases serotonin transporter (SERT) binding sites and SERT mRNA expression in discrete regions of female rat brain. Journal of Physiology London 1996, 495P:P114.
143. McQueen J.K., Wilson H., Fink G. Estradiol-17 beta increases serotonin transporter (SERT) mRNA levels and the density of SERT-binding sites in female rat brain. Molecular Brain Research 1997, 45(1):13-23.
144. Miller C.A., Sweatt J.D. Covalent modification of DNA regulates memory formation. Neuron 2007, 53(6):857-869.
145. Mize A.L., Alper R.H. Acute and long-term effects of 17beta-estradiol on G(i/o) coupled neurotransmitter receptor function in the female rat brain as assessed by agonist-stimulated [35S]GTPgammaS binding. Brain Research 2000, 859(2):326-333.
146. Mize A.L., Alper R.H. Rapid uncoupling of serotonin-1A receptors in rat hippocampus by 17beta-estradiol in vitro requires protein kinases A and C. Neuroendocrinology 2002, 76(6):339-347.
147. Mize A.L., Poisner A.M., Alper R.H. Estrogens act in rat hippocampus and frontal cortex to produce rapid, receptor-mediated decreases in serotonin 5-HT(1A) receptor function. Neuroendocrinology 2001, 73(3):166-174.
148. Mong J.A., Pfaff D.W. Hormonal symphony: Steroid orchestration of gene modules for sociosexual behaviors. Molecular Psychiatry 2004, 9(6):550-556.
149. Monteleone P., Brambilla F., Bortolotti F., Maj M. Serotonergic dysfunction across the eating disorders: Relationship to eating behaviour, purging behaviour, nutritional status and general psychopathology. Psychological Medicine 2000, 30(5):1099-1110.
150. Monteleone P., Maj M. Genetic susceptibility to eating disorders: Associated polymorphisms and pharmacogenetic suggestions. Pharmacogenomics 2008, 9(10):1487-1520.
151. Monti J.M., Jantos H. Effects of activation and blockade of 5-HT2A/2C receptors in the dorsal raphe nucleus on sleep and waking in the rat. Progress in Neuropsychopharmacology & Biological Psychiatry 2006, 30(7):1189-1195.
152. Moreau J.L., Griebel G., Jenck F., Martin J.R., Widmer U., Haefely W.E. Behavioral profile of the 5HT1A receptor antagonist (S)-UH-301 in rodents and monkeys. Brain Research Bulletin 1992, 29(6):901-904. [Article].
153. Moresco F.M., Dieci M., Vita A., Messa C., Gobbo C., Galli L., et al. In vivo serotonin 5HT(2A) receptor binding and personality traits in healthy subjects: A positron emission tomography study. Neuroimage 2002, 17(3):1470-1478.
154. Morgan M.A., Schulkin J., Pfaff D.W. Estrogens and non-reproductive behaviors related to activity and fear. Neuroscience and Biobehavioral Reviews 2004, 28(1):55-63.
155. Murphy D.L., Fox M.A., Timpano K.R., Moya P.R., Ren-Patterson R., Andrews A.M., et al. How the serotonin story is being rewritten by new gene-based discoveries principally related to SLC6A4, the serotonin transporter gene, which functions to influence all cellular serotonin systems. Neuropharmacology 2008, 55(6):932-960.
156. Murphy D.L., Uhl G.R., Holmes A., Ren-Patterson R., Hall F.S., Sora I., et al. Experimental gene interaction studies with SERT mutant mice as models for human polygenic and epistatic traits and disorders. Genes, Brain, and Behavior 2003, 2(6):350-364.
157. Nacmias B., Ricca V., Tedde A., Mezzani B., Rotella C.M., Sorbi S. 5-HT2A receptor gene polymorphisms in anorexia nervosa and bulimia nervosa. Neuroscience Letters 1999, 277(2):134-136.
158. Nishiguchi N., Matsushita S., Suzuki K., Murayama M., Shirakawa O., Higuchi S. Association between 5HT2A receptor gene promoter region polymorphism and eating disorders in Japanese patients. Biological Psychiatry 2001, 50(2):123-128.
159. Nomura M., Kusumi I., Kaneko M., Masui T., Daiguji M., Ueno T., et al. Involvement of a polymorphism in the 5-HT2A receptor gene in impulsive behavior. Psychopharmacology 2006, 187(1):30-35.
160. Ogawa S., Chan J., Gustafsson J.A., Korach K.S., Pfaff D.W. Estrogen increases locomotor activity in mice through estrogen receptor alpha: Specificity for the type of activity. Endocrinology 2003, 144(1):230-239.
161. Ogawa S., Choleris E., Pfaff D. Genetic influences on aggressive behaviors and arousability in animals. Annals of the New York Acadamey of Science 2004, 1036:257-266.
162. Ogren S.O., Eriksson T.M., Elvander-Tottie E., D'Addario C., Ekstrom J.C., Svenningsson P., et al. The role of 5-HT1A receptors in learning and memory. Behavioural Brain Research 2008, 195(1):54-77.
163. Overstreet D.H., Commissaris R.C., De La Garza R., File S.E., Knapp D.J., Seiden L.S. Involvement of 5-HT1A receptors in animal tests of anxiety and depression: Evidence from genetic models. Stress 2003, 6(2):101-110.
164. Parker G.C., Coscina D.V. Lesions of the posterior basolateral amygdala block feeding induced by systemic 8-OH-DPAT. Pharmacology, Biochemistry and Behavior 2001, 68(4):729-734.
165. Passamonti L., Cerasa A., Gioia M.C., Magariello A., Muglia M., Quattrone A., et al. Genetically dependent modulation of serotonergic inactivation in the human prefrontal cortex. Neuroimage 2008, 40(3):1264-1273.
166. Pazos A., Probst A., Palacios J.M. Serotonin receptors in the human brain-IV. Autoradiographic mapping of serotonin-2 receptors. Neuroscience 1987, 21(1):123-139.
167. Pecins-Thompson M., Bethea C.L. Ovarian steroid regulation of serotonin-1A autoreceptor messenger RNA expression in the dorsal raphe of rhesus macaques. Neuroscience 1999, 89(1):267-277.
168. Pecins-Thompson M., Brown N.A., Kohama S.G., Bethea C.L. Ovarian steroid regulation of tryptophan hydroxylase mRNA expression in rhesus macaques. The Journal of Neuroscience 1996, 16(21):7021-7029.
169. Pfaff D.W. Brain arousal and information theory: Neural and genetic mechanisms 2005, Harvard University Press, Cambridge, MA.
170. Pfaff D.W. Hormone-driven mechanisms in the central nervous system facilitate the analysis of mammalian behaviours. The Journal of Endocrinology 2005, 184(3):447-453.
171. Pfaff D.W., Banavar J.R. A theoretical framework for CNS arousal. Bioessays 2007, 29(8):803-810.
172. Philibert R.A., Sandhu H., Hollenbeck N., Gunter T., Adams W., Madan A. The relationship of 5HTT (SLC6A4) methylation and genotype on mRNA expression and liability to major depression and alcohol dependence in subjects from the Iowa Adoption Studies. American Journal of Medical Genetics. Part B: Neuropsychiatric Genetics 2008, 147B(5):543-549.
173. Pope H.G., Hudson J.I., Jonas J.M., Yurgelun-Todd D. Bulimia treated with imipramine: A placebo-controlled, double-blind study. The American Journal of Psychiatry 1983, 140(5):554-558.
174. Poyastro Pinheiro A., Thornton L.M., Plotonicov K.H., Tozzi F., Klump K.L., Berrettini W.H., et al. Patterns of menstrual disturbance in eating disorders. The International Journal of Eating Disorders 2007, 40(5):424-434.
175. Price W.A., Torem M.S., DiMarzio L.R. Premenstrual exacerbation of bulimia. Psychosomatics 1987, 28(7):378-379.
176. Qiu J., Bosch M.A., Tobias S.C., Krust A., Graham S.M., Murphy S.J., et al. A G-protein-coupled estrogen receptor is involved in hypothalamic control of energy homeostasis. The Journal of Neuroscience 2006, 26(21):5649-5655.
177. Resko J.A., Roselli C.E. Prenatal hormones organize sex differences of the neuroendocrine reproductive system: Observations on guinea pigs and nonhuman primates. Cellular and Molecular Neurobiology 1997, 17(6):627-648.
178. Ricca V., Nacmias B., Cellini E., Di Bernardo M., Rotella C.M., Sorbi S. 5-HT2A receptor gene polymorphism and eating disorders. Neuroscience Letters 2002, 323(2):105-108.
179. Roberts S., Kenney N.J., Mook D.G. Overeating induced by progesterone in ovariectomized, adrenalectomized rat. Hormones and Behavior 1972, 3(3):267-276.
180. Rodier W.I. Progesterone-estrogen interaction in control of activity-wheel running in female rat. Journal of Comparative and Physiological Psychology 1971, 74(3):365-373.
181. Roepke T.A., Qiu J., Bosch M.A., Ronnekleiv O.K., Kelly M.J. Cross-talk between membrane-initiated and nuclear-initiated oestrogen signalling in the hypothalamus. Journal of Neuroendocrinology 2009, 21(4):263-270.
182. Roepke T.A., Xue C., Bosch M.A., Scanlan T.S., Kelly M.J., Ronnekleiv O.K. Genes associated with membrane-initiated signaling of estrogen and energy homeostasis. Endocrinology 2008, 149(12):6113-6124.
183. Rubin B.S., Murray M.K., Damassa D.A., King J.C., Soto A.M. Perinatal exposure to low doses of bisphenol A affects body weight, patterns of estrous cyclicity, and plasma LH levels. Environmental Health Perspectives 2001, 109(7):675-680.
184. Rudnick G. Serotonin transporters - Structure and function. The Journal of Membrane Biology 2006, 213(2):101-110.
185. Sabine E.J., Yonace A., Farrington A.J., Barratt K.H., Wakeling A. Bulimia nervosa: A placebo controlled double-blind therapeutic trial of mianserin. British Journal of Clinical Pharmacology 1983, 15(Suppl 2):195S-202S.
186. Saiz P.A., Garcia-Portilla M.P., Arango C., Morales B., Bascaran M.T., Martinez-Barrondo S., et al. Association study between obsessive-compulsive disorder and serotonergic candidate genes. Progress in Neuropsychopharmacology & Biological Psychiatry 2008, 32(3):765-770.
187. Sanders-Bush E. Adaptive regulation of central serotonin receptors linked to phosphoinositide hydrolysis. Neuropsychopharmacology 1990, 3(5-6):411-416.
188. Saura J., Kettler R., Daprada M., Richards J.G. Quantitative enzyme autoradiography with H-3 RO 41-1049 and H-3 R0 19-6327 in vitro - Localization and abundance of MAO-A and MAO-B in rat CNS, peripheral organs, and human brain. The Journal of Neuroscience 1992, 12(5):1977-1999. [Article].
189. Schneider L.S., Small G.W., Clary C.M. Estrogen replacement therapy and antidepressant response to sertraline in older depressed women. The American Journal of Geriatric Psychiatry 2001, 9(4):393-399.
190. Schwartz M.W., Woods S.C., Porte D., Seeley R.J., Baskin D.G. Central nervous system control of food intake. Nature 2000, 404(6778):661-671.
191. Sell S.L., Craft R.M., Seitz P.K., Stutz S.J., Cunningham K.A., Thomas M.L. Estradiol-sertraline synergy in ovariectomized rats. Psychoneuroendocrinology 2008, 33(8):1051-1060.
192. Shapiro J.R., Berkman N.D., Brownley K.A., Sedway J.A., Lohr K.N., Bulik C.M. Bulimia nervosa treatment: A systematic review of randomized controlled trials. The International Journal of Eating Disorders 2007, 40(4):321-336.
193. Shelley D.N., Dwyer E., Johnson C., Wittkowski K.M., Pfaff D.W. Interactions between estrogen effects and hunger effects in ovariectomized female mice. I. Measures of arousal. Hormones and Behavior 2007, 52(4):546-553.
194. Shi H., Clegg D.J. Sex differences in the regulation of body weight. Physiology & Behavior 2009, 97(2):199-204.
195. Shughrue P.J., Merchenthaler I. Distribution of estrogen receptor beta immunoreactivity in the rat central nervous system. The Journal of Comparative Neurology 2001, 436(1):64-81.
196. Shughrue P.J., Scrimo P.J., Merchenthaler I. Evidence for the colocalization of estrogen receptor-beta mRNA and estrogen receptor-alpha immunoreactivity in neurons of the rat forebrain. Endocrinology 1998, 139(12):5267-5270.
197. Shughrue P.J., Scrimo P.J., Merchenthaler I. Estrogen binding and estrogen receptor characterization (ER alpha and ER beta) in the cholinergic neurons of the rat basal forebrain. Neuroscience 2000, 96(1):41-49.
198. Smith L.J., Henderson J.A., Abell C.W., Bethea C.L. Effects of ovarian steroids and raloxifene on proteins that synthesize, transport, and degrade serotonin in the raphe region of macaques. Neuropsychopharmacology 2004, 29(11):2035-2045.
199. Smyth J.M., Heron K.E., Sliwinski M.J., Wonderlich S.A., Crosby R.D., Mitchell J.E., et al. Daily and momentary mood and stress are associated with binge eating and vomiting in bulimia nervosa patients in the natural environment. Journal of Consulting and Clinical Psychology 2007, 75(4):629-638.
200. Soulairac A. Neurological factors in the control of the appetite. International Review of Neurobiology 1963, 5:303-346.
201. Spencer J.L., Waters E.M., Romeo R.D., Wood G.E., Milner T.A., McEwen B.S. Uncovering the mechanisms of estrogen effects on hippocampal function. Frontiers in Neuroendocrinology 2008, 29(2):219-237.
202. Steiger H. Eating disorders and the serotonin connection: State, trait and developmental effects. Journal of Psychiatry & Neuroscience 2004, 29(1):20-29.
203. Steiger H., Bruce K.R. Phenotypes, endophenotypes, and genotypes in bulimia spectrum eating disorders. Canadian Journal of Psychiatry 2007, 52(4):220-227.
204. Steiger H., Gauvin L., Engelberg M.J., Bruce K.R., Israel M., Kin N.Y., et al. Serotonin-based moderation of binge antecedents in bulimia nervosa: Does abnormal serotonin function favor restraint- or emotion-based pathways to binge eating?. The International Journal of Eating Disorders 2004, 35(4):085.
205. Steiger H., Koerner N., Engelberg M.J., Israel M., Ng Ying Kin N.M., Young S.N. Self-destructiveness and serotonin function in bulimia nervosa. Psychiatry Research 2001, 103(1):15-26.
206. Steiger H., Young S.N., Kin N.M., Koerner N., Israel M., Lageix P., et al. Implications of impulsive and affective symptoms for serotonin function in bulimia nervosa. Psychological Medicine 2001, 31(1):85-95.
207. Stein D.J., Hollander E., DeCaria C.M., Simeon D., Cohen L., Aronowitz B. m-Chlorophenylpiperazine challenge in borderline personality disorder: Relationship of neuroendocrine response, behavioral response, and clinical measures. Biological Psychiatry 1996, 40(6):508-513.
208. Strober M., Freeman R., Morrell W. The long-term course of severe anorexia nervosa in adolescents: Survival analysis of recovery, relapse, and outcome predictors over 10-15years in a prospective study. The International Journal of Eating Disorders 1997, 22(4):339-360.
209. Sullivan P.F., Bulik C.M., Kendler K.S. Genetic epidemiology of binging and vomiting. The British Journal of Psychiatry 1998, 173:75-79.
210. Sumner B.E., Grant K.E., Rosie R., Hegele-Hartung C., Fritzemeier K.H., Fink G. Effects of tamoxifen on serotonin transporter and 5-hydroxytryptamine(2A) receptor binding sites and mRNA levels in the brain of ovariectomized rats with or without acute estradiol replacement. Brain Research. Molecular Brain Research 1999, 73(1-2):119-128.
211. Sumner B.E., Grant K.E., Rosie R., Hegele-Hartung C., Fritzemeier K.H., Fink G. Raloxifene blocks estradiol induction of the serotonin transporter and 5-hydroxytryptamine(2A) receptor in female rat brain. Neuroscience Letters 2007, 417(1):95-99.
212. Szyf M., Weaver I., Meaney M. Maternal care, the epigenome and phenotypic differences in behavior. Reproductive Toxicology 2007, 24(1):9-19.
213. Tauscher J., Pirker W., Willeit M., de Zwaan M., Bailer U., Neumeister A., et al. [I-123] beta-CIT and single photon emission computed tomography reveal reduced brain serotonin transporter availability in bulimia nervosa. Biological Psychiatry 2001, 49(4):326-332.
214. Thammacharoen S., Geary N., Lutz T.A., Ogawa S., Asarian L. Divergent effects of estradiol and the estrogen receptor-alpha agonist PPT on eating and activation of PVN CRH neurons in ovariectomized rats and mice. Brain Research 2009, 1268:88-96.
215. Tiihonen J., Keski-Rahkonen A., Lopponen M., Muhonen M., Kajander J., Allonen T., et al. Brain serotonin 1A receptor binding in bulimia nervosa. Biological Psychiatry 2004, 55(8):871-873.
216. Toufexis D.J., Myers K.M., Bowser M.E., Davis M. Estrogen disrupts the inhibition of fear in female rats, possibly through the antagonistic effects of estrogen receptor alpha (ER alpha) and ER beta. The Journal of Neuroscience 2007, 27(36):9729-9735.
217. Tremblay G.B., Tremblay A., Copeland N.G., Gilbert D.J., Jenkins N.A., Labrie F., et al. Cloning, chromosomal localization, and functional analysis of the murine estrogen receptor beta. Molecular Endocrinology 1997, 11(3):353-365.
218. Uphouse L. Multiple serotonin receptors: Too many, not enough, or just the right number?. Neuroscience and Biobehavioral Reviews 1997, 21(5):679-698.
219. Uphouse L., Hiegel C., Perez E., Guptarak J. Serotonin receptor involvement in effects of restraint on female rat lordosis behavior. Pharmacology, Biochemistry and Behavior 2007, 86(4):631-636.
220. Vogel C., Mossner R., Gerlach M., Heinemann T., Murphy D.L., Riederer P., et al. Absence of thermal hyperalgesia in serotonin transporter-deficient mice. The Journal of Neuroscience 2003, 23(2):708-715.
221. Wade G.N. Some effects of ovarian hormones on food-intake and body-weight in female rats. Journal of Comparative and Physiological Psychology 1975, 88(1):183-193.
222. Walf A.A., Frye C.A. Conjugated equine estrogen enhances rats' cognitive, anxiety, and social behavior. NeuroReport 2008, 19(7):789-792.
223. Walf A.A., Frye C.A. Rapid and estrogen receptor beta mediated actions in the hippocampus mediate some functional effects of estrogen. Steroids 2008, 73(9-10):997-1007.
224. Walsh B.T., Agras W.S., Devlin M.J., Fairburn C.G., Wilson G.T., Kahn C., et al. Fluoxetine for bulimia nervosa following poor response to psychotherapy. The American Journal of Psychiatry 2000, 157(8):1332-1334.
225. Weaver I.C.G., Meaney M.J., Szyf M. Maternal care effects on the hippocampal transcriptome and anxiety-mediated behaviors in the offspring that are reversible in adulthood. Proceedings of the National Academy of Sciences of the United States of America 2006, 103(9):3480-3485.
226. Weiser M.J., Foradori C.D., Handa R.J. Estrogen receptor beta in the brain: From form to function. Brain Research Reviews 2008, 57(2):309-320.
227. Westlund K.N., Denney R.M., Kochersperger L.M., Rose R.M., Abell C.W. Distinct monoamine oxidase-A and oxidase-B populations in primate brain. Science 1985, 230(4722):181-183.
228. Westlund K.N., Denney R.M., Rose R.M., Abell C.W. Localization of distinct monoamine-oxidase A and monoamine-oxidase B-cell populations in human brain stem. Neuroscience 1988, 25(2):439-456.
229. Wisor J.P., Wurts S.W., Hall F.S., Lesch K.P., Murphy D.L., Uhl G.R., et al. Altered rapid eye movement sleep timing in serotonin transporter knockout mice. NeuroReport 2003, 14(2):233-238.
230. Wolfe B.E., Metzger E.D., Levine J.M., Finkelstein D.M., Cooper T.B., Jimerson D.C. Serotonin function following remission from bulimia nervosa. Neuropsychopharmacology 2000, 22(3):257-263.
231. Yan L., Ge H., Li H., Lieber S.C., Natividad F., Resuello R.R., et al. Gender-specific proteomic alterations in glycolytic and mitochondrial pathways in aging monkey hearts. Journal of Molecular and Cellular Cardiology 2004, 37(5):921-929.
232. Yokoyama S., Sugiyama N., Sugiyama E., Amano N. Five female cases of prolonged depression in chronic anorexia nervosa treated with selective estrogen receptor modulator raloxifene-augmented therapy. Journal of Clinical Psychopharmacology 2008, 28(6):721-722.
233. Yu Z.P., Geary N., Corwin R.L. Ovarian hormones inhibit fat intake under binge-type conditions in ovariectomized rats. Physiology & Behavior 2008, 95(3):501-507.
234. Zanardi R., Rossini D., Magri L., Malaguti A., Colombo C., Smeraldi E. Response to SSRIs and role of the hormonal therapy in post-menopausal depression. European Neuropsychopharmacology 2007, 17(6-7):400-405. [Article].
235. Zhao S., Edwards J., Carroll J., Wiedholz L., Millstein R.A., Jaing C., et al. Insertion mutation at the C-terminus of the serotonin transporter disrupts brain serotonin function and emotion-related behaviors in mice. Neuroscience 2006, 140(1):321-334.
236. Zhou W.X., Koldzic-Zivanovic N., Clarke C.H., de Beun R., Wassermann K., Bury P.S., et al. Selective estrogen receptor modulator effects in the rat brain. Neuroendocrinology 2002, 75(1):24-33.
237. Zucker I. Hormonal determinants of sex differences in saccharin preference, food intake and body weight. Physiology & Behavior 1969, 4(4):595-602.